cellular
• decreased sensitivity to anti-Fas antibody-induced liver apoptosis
• higher survival rates 24 hours after anti-Fas antibody injection (87% versus 15% wild-type)
• no hemorrhagic lesions
• fewer apoptotic markers
|
liver/biliary system
• decreased sensitivity to anti-Fas antibody-induced liver apoptosis
• higher survival rates 24 hours after anti-Fas antibody injection (87% versus 15% wild-type)
• no hemorrhagic lesions
• fewer apoptotic markers
|